v3.25.4
Stock Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Stock Compensation [Abstract]  
Schedule of Non-vested Restricted Stock

The following table summarizes the status of the Company’s non-vested restricted stock awards for years ended December 31, 2025:

 

   Non-vested
Restricted Stock Awards
 
   Number of
Shares
   Weighted
Average
Grant Date
Fair Value
 
Outstanding at December 31, 2024   
-
   $41,280 
Granted   
-
    
-
 
Vested   (-)   41,280 
Cancelled / forfeited   
-
    
-
 
Outstanding at December 31, 2025   
-
   $
-
 
Schedule of Stock Option Activity

The following is a summary of stock option activity for the year ended December 31, 2025:

 

   Number of
Stock
Options
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Life in
Years
   Aggregate
Intrinsic 
Value
 
Outstanding at December 31, 2024   18   $59,864    5.8   $
      -
 
Granted   
-
    
-
         
-
 
Exercised   
-
    
-
         
-
 
Cancelled / forfeited   (13)   75,052         
-
 
Outstanding at December 31, 2025   5   $20,376    3.0   $
-
 
Exercisable at December 31, 2025   5   $20,376    3.0   $
-
 
Schedule of Stock-Based Compensation Expense

For the years ended December 31, 2025 and 2024, the Company recorded stock-based compensation expense as follows:

 

   Year ended
December 31,
 
   2025   2024 
Research and development  $(193)  $16,648 
General and administrative   199    3,446 
Marketing and business development   
-
    
-
 
Total stock-based compensation  $6   $20,094